The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $688,750 in first-year total cost, median $233,250.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMM-K (52)]3
Most frequent institutions
- ROCKEFELLER UNIVERSITY1
- UNIVERSITY OF COLORADO DENVER1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Inherited IRF9 deficiency: a novel genetic etiology of severe influenza1R21AI137371-01 | CASANOVA, JEAN-LAURENT | ROCKEFELLER UNIVERSITY, NY | $254,250 | ZRG1 |
| 2018 | A Novel Approach to Evaluate Genetic Variants in Primary Antibody Deficiency1R21AI133110-01A1 | WANG, JING HONG | UNIVERSITY OF COLORADO DENVER, CO | $233,250 | ZRG1 |
| 2018 | The Role of Post-translational Modifier PRMT5 in Regulatory T cell Development and Function1R21AI135359-01 | GREENE, MARK IKAMBAYASHI, TAKU | UNIVERSITY OF PENNSYLVANIA, PA | $201,250 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.